FHTX — Foghorn Therapeutics. Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Foghorn Therapeutics., fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15	186	154	346	234
Net Total Receivables	—	—	300	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	16.9	191	460	351	240
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.71	62.3	56.1	49.4	42.9
Other Long Term Assets
Total Assets	22.3	256	520	405	286
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.7	18.8	48.7	55.2	58.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23.8	109	423	405	363
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.47	146	96.9	0.112	-77.2
Total Liabilities & Shareholders' Equity	22.3	256	520	405	286
Total Common Shares Outstanding